CD44+ Cells in Head and Neck Squamous Cell Carcinoma Suppress T-Cell–Mediated Immunity by Selective Constitutive and Inducible Expression of PD-L1

MLA

Hua Wang, et al. “CD44+ Cells in Head and Neck Squamous Cell Carcinoma Suppress T-Cell–Mediated Immunity by Selective Constitutive and Inducible Expression of PD-L1.” Clinical Cancer Research, vol. 22, July 2016, pp. 3571–81. EBSCOhost, https://doi.org/10.1158/1078-0432.ccr-15-2665.

APA

Hua Wang, Michelle Longmire, Howard Y. Chang, Yunqin Lee, John B. Sunwoo, June Ho Shin, & Holbrook E Kohrt. (2016). CD44+ Cells in Head and Neck Squamous Cell Carcinoma Suppress T-Cell–Mediated Immunity by Selective Constitutive and Inducible Expression of PD-L1. Clinical Cancer Research, 22, 3571–3581. https://doi.org/10.1158/1078-0432.ccr-15-2665

Chicago

Hua Wang, Michelle Longmire, Howard Y. Chang, Yunqin Lee, John B. Sunwoo, June Ho Shin, and Holbrook E Kohrt. 2016. “CD44+ Cells in Head and Neck Squamous Cell Carcinoma Suppress T-Cell–Mediated Immunity by Selective Constitutive and Inducible Expression of PD-L1.” Clinical Cancer Research 22 (July): 3571–81. doi:10.1158/1078-0432.ccr-15-2665.